Midcap

F.N.B. Corporation Named a Standout Commercial Bank for Commitment to ESG

Retrieved on: 
Tuesday, May 24, 2022
High Point, Piedmont Triad, Social Security Government Pension Offset, Capital, Small business, Standard, Company, Currency, Midcap, FNB, First National Bank, New, Investment, Multimedia, Insurance, Award, Government, F.N.B. Corporation, Solution, Comptroller, Blake Paulson, Community, S&P Global Ratings, Global, Commitment, GICS, Corporation, Winston-Salem, North Carolina, NYSE, Social, District, ESG, Financial services

PITTSBURGH, May 24, 2022 /PRNewswire/ -- F.N.B. Corporation (NYSE: FNB) announced that it has been named to Coalition Greenwich's inaugural list of Standout Commercial Banks for Demonstrating Commitment to Environmental, Social and Governance (ESG) Principles and Values. FNB was one of only nine banks in the country to receive the recognition.

Key Points: 
  • Corporation (NYSE: FNB) announced that it has been named to Coalition Greenwich's inaugural list of Standout Commercial Banks for Demonstrating Commitment to Environmental, Social and Governance (ESG) Principles and Values.
  • To identify the standout banks, Coalition Greenwich, formerly Greenwich Associates, asked more than 20,000 small business and middle market executives to assess their banks' commitment to ESG.
  • "Corporate responsibility, including ESG, is a vital cultural and strategic priority for FNB," said Vincent J. Delie, Jr., Chairman, President and Chief Executive Officer of F.N.B.
  • For a comprehensive overview of FNB's community commitment and ESG practices, please review its Corporate Responsibility Report .

FNB Announces $2.5 Million Commitment to Black Tech Nation Ventures

Retrieved on: 
Tuesday, May 17, 2022
High Point, Piedmont Triad, Small business, Education, Software, Company, Standard, Midcap, FNB, Housing, First National Bank, New, Multimedia, Investment, VC, Insurance, Government, F.N.B. Corporation, Solution, EQ2, Review, S&P Global Ratings, ABEL, Industry, Inclusion, Partnership, Urban Redevelopment Authority of Pittsburgh, Global, GICS, ReNew Power, Technology, Community development, Economic development, Corporation, Community development financial institution, Founder, Diversity, Winston-Salem, North Carolina, Growth, NYSE, District, Cryptocurrency, Renewable energy, Security (finance), Black

PITTSBURGH, May 17, 2022 /PRNewswire/ -- F.N.B. Corporation (NYSE: FNB) announced it is making a $2.5 million equity commitment to Black Tech Nation Ventures (BTN.vc), a majority Black-owned venture capital fund based in Pittsburgh, PA. BTN.vc provides funding and resources for Black-led technology startups and firms with diverse founders and teams, with a goal of enabling wealth creation for underrepresented entrepreneurs in FNB's seven-state footprint and across the United States.

Key Points: 
  • "Black Tech Nation Ventures has a proven leadership team and a mission that aligns with our own focus on providing resources for diverse communities," said Vincent J. Delie, Jr., Chairman, President and Chief Executive Officer of F.N.B.
  • In addition to funding, BTN.vc connects entrepreneurs with education and consultative resources provided by its sister company, Black Tech Nation , a national community of Black technology professionals, innovators, entrepreneurs and industry partners.
  • Kelauni Jasmyn, a BTN.vc Founding Partner and the Founder and Chief Executive Officer of Black Tech Nation, said, "We are happy to be in partnership with FNB and appreciate their commitment to support Black Tech Nation Ventures' mission to democratize access to VC capital and generate wealth for marginalized communities.
  • We look forward to working with FNB to create a substantial impact in tech and VC."

Exicure, Inc. Reports First Quarter 2022 Financial Results and Corporate Progress

Retrieved on: 
Monday, May 16, 2022
Biotechnology, Health, Genetics, Science, Research, Research and development, Pain, Company, R, Private Securities Litigation Reform Act, Midcap, G&A, Research, U.S. Securities and Exchange Commission, AbbVie, Patient, Investment, NASDAQ, Clinical trial, COVID-19, Patent, PIPE, Intellectual property, Forward-looking statement, Board, Ipsen, RNA, Safety, SCN9A, Attention, Drug development, Corporation, Administration, Security (finance), Neuroscience, CBI, Hair loss, Lists of diseases, Achievement, Pharmaceutical industry, Video game, Airline

Transaction is expected to close on or about May 19, 2022, subject to the satisfaction of customary closing conditions.

Key Points: 
  • Transaction is expected to close on or about May 19, 2022, subject to the satisfaction of customary closing conditions.
  • Corporate highlights for the first quarter of 2022 include:
    Repaid in full all outstanding indebtedness and other obligations under the Companys credit facility with MidCap, effective March 15, 2022.
  • Exicure anticipates results from initial in vivo animal studies by year-end 2022, with the goal of therapeutic candidate selection in the second half of 2023.
  • Revenue: Revenue was $2.6 million for the quarter ended March 31, 2022, reflecting an increase of $1.6 million from revenue of $1.0 million for the quarter ended March 31, 2021.

FNB Receives Multiple Awards for Differentiated Culture

Retrieved on: 
Monday, May 16, 2022
High Point, Piedmont Triad, Small business, Company, Georgia Railroad and Banking Company, Standard, Midcap, World, Millennial Women, FNB, First National Bank, Forbes, New, Multimedia, Award, Insurance, Leadership, F.N.B. Corporation, Solution, Government, Workplace, Decision-making, S&P Global Ratings, Culture, Global, GICS, District, Organization, Woman, Growth, Recognition, Winston-Salem, North Carolina, NYSE, Innovation, Property management, Management, Medicine

PITTSBURGH, May 16, 2022 /PRNewswire/ -- F.N.B. Corporation (NYSE: FNB) announced that its banking subsidiary, First National Bank, has been recognized with three Top Workplaces 2022 Culture Excellence awards for Innovation, Leadership and Work-Life Flexibility. These national awards celebrate organizations that excel in specific areas of workplace culture.

Key Points: 
  • Corporation (NYSE: FNB) announced that its banking subsidiary, First National Bank, has been recognized with three Top Workplaces 2022 Culture Excellence awards for Innovation, Leadership and Work-Life Flexibility.
  • These national awards celebrate organizations that excel in specific areas of workplace culture.
  • The Company has earned a total of more than 40 national and regional awards for its workplace experience.
  • FNB's recent Top Workplaces awards add to the extensive recognition it has received for its differentiated culture, which focuses on doing what is right for all of its stakeholders.

IMB Partners Leads Growth Investment in Carr & Duff

Retrieved on: 
Thursday, May 5, 2022
Professional Services, Finance, EBITDA, Midcap, Delaware Valley, Partnership, Duff, Government, IMB, Partner, Oaktree Capital Management, PE, Aviation in the Philadelphia metropolitan area, C&D, Life, CEO, Public utility, Financial services

IMB Partners, a leading middle market private equity firm specializing in utility and government agency services, is announcing its strategic investment in Carr & Duff, a southeastern Pennsylvania corporation that provides specialty electrical construction services to a range of mid-Atlantic customers.

Key Points: 
  • IMB Partners, a leading middle market private equity firm specializing in utility and government agency services, is announcing its strategic investment in Carr & Duff, a southeastern Pennsylvania corporation that provides specialty electrical construction services to a range of mid-Atlantic customers.
  • The Duff brothers, Bob, Eddie and Jack, will remain with the business after IMBs investment, will continue to work in leadership roles and will have meaningful ownership going forward.
  • Carr & Duff fits our expanding portfolio and our team is pleased to have Bob, Eddie and Jack on board with the business to grow the company, said Tarrus Richardson, IMB Partners Founder & CEO.
  • IMB seeks platform investment targets with $5-$25 million in EBITDA and will go as low as $1 million in EBITDA for add-on investments.

Exelixis To Webcast Fireside Chats as Part of Investor Conferences in May

Retrieved on: 
Wednesday, May 4, 2022
Science, Biotechnology, Research, Pharmaceutical, Oncology, General Health, Health, Clinical Trials, Twitter, Nasdaq, Daiichi Sankyo, Midcap, Software, EXEL, Bank of America, Drug discovery, Patient, Calendar, Investor, News, Conference, Genetics, Esaxerenone, Cancer, S&P, Standard, Genentech, Pharmaceutical industry, Kerosene, Exelixis, Facebook, Limited

Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the companys management team will participate in fireside chats at the following investor conferences in May:

Key Points: 
  • Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the companys management team will participate in fireside chats at the following investor conferences in May:
    BofA Securities 2022 Healthcare Conference: Exelixis is scheduled to present at 1:40 p.m.
  • 2022 RBC Capital Markets Global Healthcare Conference: Exelixis is scheduled to present at 8:30 a.m.
  • For more information about Exelixis, please visit www.exelixis.com , follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
  • Exelixis, the Exelixis logo, CABOMETYX and COMETRIQ are registered U.S. trademarks of Exelixis.

FNB Names Jennifer Reel Chief Communications Officer

Retrieved on: 
Tuesday, May 3, 2022
Corporate communication, Westminster, ABA, First National Bank, Insurance, F.N.B. Corporation, American Bankers Association, Reel, High Point, New, Company, NYSE, Public Relations Society of America, Midcap, GICS, Communication, Industry, District, Government Secondary School, North Bank, Winston-Salem, North Carolina, Leadership, Public relations, Government, Institute, FNB, Marketing, Small business, Standard, Global, S&P Global Ratings, Solution, Piedmont Triad, Growth, Multimedia, Management

Corporation (NYSE: FNB) and its banking subsidiary, First National Bank, announced that Jennifer M. Reel has been named Chief Communications Officer.

Key Points: 
  • Corporation (NYSE: FNB) and its banking subsidiary, First National Bank, announced that Jennifer M. Reel has been named Chief Communications Officer.
  • Reporting directly to Chairman, President and Chief Executive Officer Vincent J. Delie, Jr., Reel is responsible for ensuring that FNB clearly communicates its strategic vision, roadmap and messaging across all its constituents.
  • "Jennifer already has brought invaluable leadership and perspective to FNB's growth and communications plans," said Delie.
  • She has held various Marketing and Communications roles at FNB throughout the Company's significant expansion, most recently serving as Director of Corporate Communications.

Exelixis to Release First Quarter 2022 Financial Results on Tuesday, May 10, 2022

Retrieved on: 
Tuesday, April 26, 2022
Oncology, Health, Genetics, General Health, Pharmaceutical, Biotechnology, Esaxerenone, Daiichi Sankyo, Internet, EXEL, Midcap, Calendar, Twitter, Genetics, Software, Drug discovery, News, Patient, Nasdaq, Genentech, Webcast, S&P, Cancer, Standard, Investor, Pharmaceutical industry, Kerosene, Exelixis, Limited, Facebook

Exelixis, Inc. (Nasdaq: EXEL) announced today that its first quarter 2022 financial results will be released on Tuesday, May 10, 2022 after the markets close.

Key Points: 
  • Exelixis, Inc. (Nasdaq: EXEL) announced today that its first quarter 2022 financial results will be released on Tuesday, May 10, 2022 after the markets close.
  • ET / 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss the results and provide a general business update.
  • For more information about Exelixis, please visit www.exelixis.com , follow @ ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
  • Exelixis, the Exelixis logo, CABOMETYX and COMETRIQ are registered U.S. trademarks of Exelixis.

FNB Again Named One of the World's Best Banks by Forbes

Retrieved on: 
Thursday, April 14, 2022
Piedmont Triad, Government, GICS, New, Culture, Midcap, Small business, Workplace, District, Statista, S&P Global Ratings, World, Technology, FNB, Winston-Salem, North Carolina, Insurance, Company, Solution, Standard, F.N.B. Corporation, NYSE, First National Bank, Multimedia, Global, Trust, High Point, Recognition, Forbes

Corporation (NYSE: FNB) announced that its banking subsidiary, First National Bank, has been ranked by Forbes as one of the World's Best Banks for a second consecutive year.

Key Points: 
  • Corporation (NYSE: FNB) announced that its banking subsidiary, First National Bank, has been ranked by Forbes as one of the World's Best Banks for a second consecutive year.
  • FNB is one of only 75 banks in the United States, and 435 worldwide, to be included in the 2022 rankings, which are based solely on consumer feedback.
  • Thus far in 2022, FNB again has been named as one of America's Best Banks by Forbes, received 17 Greenwich Excellence and Best Brand Awards and was recognized as a Top Workplace USA by Energage for a second consecutive year.
  • F.N.B.

Exelixis Announces Initiation of First-In-Human Phase 1 Trial Evaluating XL114 Monotherapy in Patients with Non-Hodgkin’s Lymphoma

Retrieved on: 
Thursday, April 14, 2022
Biotechnology, Pharmaceutical, Health, Oncology, Statistics, Esaxerenone, Cancer, Daiichi Sankyo, Chronic lymphocytic leukemia, Clinical trial, EXEL, Midcap, U.S. Securities and Exchange Commission, COVID-19, Twitter, Risk, Genetics, Research, NHL, Annual report, T cell, Neelapu Rami Reddy, Compliance, Mantle cell lymphoma, Drug discovery, Security (finance), Patient, Nasdaq, Genentech, American Cancer Society, T-cell lymphoma, Lymphoma, B-cell lymphoma, SEC, S&P, Forward-looking statement, Lymphatic system, Safety, DLBCL, Medical Affairs Bureau, Blood, Natural killer cell enteropathy, Standard, Survival, Pharmaceutical industry, Vaccine, Kerosene, Platinum, Exelixis, S.S, Limited, Facebook

The dose-escalation stage will determine the recommended dose of XL114 in patients with advanced B- and T-cell NHL.

Key Points: 
  • The dose-escalation stage will determine the recommended dose of XL114 in patients with advanced B- and T-cell NHL.
  • As announced last year, Exelixis in-licensed XL114 from Aurigene Discovery Technologies Limited under the companies July 2019 collaboration, option and license agreement.
  • Exelixis assumed responsibility for the future clinical development, commercialization and global manufacturing of XL114.
  • For more information about Exelixis, please visit www.exelixis.com , follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.